• OPEN AN ACCOUNT
Indian Indices
Sensex
76,835.78 776.01
( 1.02%)
Global Indices
Nasdaq
51,969.87 237.22
(0.46%)
Dow Jones
7,434.30 5.00
(0.07%)
Hang Seng
64,889.11 277.96
(0.43%)
Nikkei 225
10,738.51 99.34
(0.93%)
Forex
USD-INR
96.67 0.19
(0.20%)
EUR-INR
110.18 0.12
(0.10%)
GBP-INR
129.04 -0.01
(0.00%)
JPY-INR
0.59 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Exide Industries Ltd
Industry :  Auto Ancillaries
BSE Code
ISIN Demat
Book Value()
500086
INE302A01020
172.6303529
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EXIDEIND
34.55
37650.75
EPS(TTM)
Face Value()
Div & Yield %
12.82
1
0.45
 

cemindia projects ltd
Tatva Chintan Pharma Chem consolidated net profit rises 901.94% in the March 2026 quarter
May 18,2026
Net profit of Tatva Chintan Pharma Chem rose 901.94% to Rs 10.32 crore in the quarter ended March 2026 as against Rs 1.03 crore during the previous quarter ended March 2025. Sales rose 24.36% to Rs 134.14 crore in the quarter ended March 2026 as against Rs 107.86 crore during the previous quarter ended March 2025.

For the full year,net profit rose 636.43% to Rs 42.05 crore in the year ended March 2026 as against Rs 5.71 crore during the previous year ended March 2025. Sales rose 32.18% to Rs 505.86 crore in the year ended March 2026 as against Rs 382.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales134.14107.86 24 505.86382.71 32
OPM %20.978.30 -18.428.94 -
PBDT26.349.29 184 93.8635.24 166
PBT16.592.03 717 57.017.58 652
NP10.321.03 902 42.055.71 636